Dermatologic problems encountered in the emergency department

American Journal of Emergency Medicine

Volumn 14, Issue 6, 1996, Pages 588-601

  Ferrera, Peter C ^a,b   Dupree, Marsha L ^a   Verdile, Vincent P ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b ALBANY MEDICAL CENTER   (United States)

Author keywords

Atopic dermatitis; atopic eczema; basal cell carcinoma; candidiasis; contact dermatitis; dermatophytoses; erythema multiforme; generalized pustular psoriasis; granuloma annulare; herpes zoster; hidradenitis suppurativa; impetigo; molluscum contagiosum; necrotizing fasciitis; pityriasis rosea; psoriasis; rosacea; scabies; seborrheic dermatitis; tinea infections; tinea versicolor; varicella; venous stasis ulcers; warts

Indexed keywords

ATOPIC DERMATITIS; BACTERIAL INFECTION; BASAL CELL CARCINOMA; CONTACT DERMATITIS; EMERGENCY MEDICINE; ERYTHEMA MULTIFORME; GRANULOMA ANNULARE; MYCOSIS; PITYRIASIS ROSEA; PRIORITY JOURNAL; PSORIASIS; REVIEW; ROSACEA; SCABIES; SKIN DISEASE; SKIN ULCER; SUPPURATIVE HIDRADENITIS; VENOUS STASIS; VIRUS INFECTION;

EID: 0029823915     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-6757(96)90108-4     Document Type: Review

References (97)

1. Przybilla B, Eberlein-Konig B, Rueff F: Practical management of atopic eczema. Lancet 1994;343:1342-1346
2. Lapidus CS, Honig PJ: Atopic dermatitis. Pediatr Rev 1994;15: 327-332
3. Hanifin JM: Atopic dermatitis in infants and children. Pediatr Clin North Am 1991;38:763-789
4. Wahlgren CF: Pathophysiology of itching in urticaria and atopic dermatitis. Allergy 1992;47:65-75.
5. Krutmann J, Czech W, Diepgen T, et al: High-dose UVA1 therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol 1992;26:225-230
6. Atherton DJ, Carabott F, Glover MT, et al: The role of psoralen photochemotherapy (PUVA) in the treatment of severe atopic eczema in adolescents. Br J Dermatol 1988;118:791-795
7. Millikan LE, Shrum JP: An update on common skin diseases. Postgrad Med 1992;91:96-115
8. Klaus MV, Wieselthier JS: Contact dermatitis. Am Fam Physician 1993;48:629-632
9. Beacham BE: Common dermatoses in the elderly. Am Fam Physician 1993;47:1445-1450
10. Krasteva M: Contact dermatitis. Int J Dermatol 1993;32:547-560
11. Agency for Toxic Substances and Disease Registry: Contact dermatitis and urticaria from environmental exposures. Am Fam Physician 1993;48:773-780
12. Harvell J, Bason M, Maibach H: Contact urticaria and its mechanisms. Food Chem Toxicol 1994;32:103-112
13. Pecquet C, Leynadier F, Dry J: Contact urticaria and anaphylaxis to natural latex. J Am Acad Dermatol 1990;22:631-633
14. Taylor JS, Cassettari J, Wagner W, et al: Contact urticaria and anaphylaxis to latex. J Am Acad Dermatol 1989;21:874-877
15. Maso MJ, Goldberg DJ: Contact dermatoses from disposable glove use: a review. J Am Acad Dermatol 1990;23:733-737
16. Ginsburg CM: Pityriasis rosea. Pediatr Infect Dis J 1991;10:858-859
17. Tunnessen WW, Jr: Picture of the month: Pityriasis rosea. Am J Dis Child 1991;145:1441-1442
18. Vidimos AT, Camisa C: Tongue and cheek: Oral lesions in pityriasis rosea. Cutis 1992;50:276-280
19. Krueger GG, Duvic M: Epidemiology of psoriasis: Clinical issues. J Invest Dermatol 1994;102:14S-18S.
20. Das UN, Vijaykumar K, Madhavi N, et al: Psoriasis: Current concepts and new approaches to therapy. Med Hyp 1992;38:56-62.
21. Helm TN, Dijkstra JWE, Ferrara RJ, et al: PUVA therapy. Am Fam Physician 1991;43:908-912.
22. Lyons JH: Generalized pustular psoriasis, Int J Dermatol 1987;26:409-418
23. Ryan TJ, Baker H: The prognosis of generalized pustular psoriasis. Br J Dermatol 1971;85:407-411
24. Ostlere LS, Akhras F, Langtry JAA, et al: Generalized pustular psoriasis associated with bacterial endocarditis of the anterior papillary muscle. Br J Dermatol 1992;127:187-188
25. Spencer JM, Silvers DN, Grossman ME: Pustular eruption after drug exposure: Is it pustular psoriasis or a pustular drug reaction? Br J Dermatol 1994;130:514-519
26. Chu T: Treatment of rosacea. Practitioner 1993;237:941-945
27. Wilkin JK: Rosacea: Pathophysiology and treatment. Arch Dermatol 1994;130:359-362
28. Bergus GR, Johnson JS: Superficial tinea infections. Am Fam Physician 1993;48:259-268
29. Odom R: Pathophysiology of dermatophyte infections. J Am Acad Dermatol 1993;28:S2-S7
30. Rezabek GH, Friedman AD: Superficial fungal infections of the skin: Diagnosis and current treatment recommendations. Drugs 1992;43:674-682
31. Nightingale SL: Warnings issued on nonsedating antihistamines terfenadine and astemizole. JAMA 1992;268:705
32. Goldgeier MH: Fungal infections of the skin, hair, and nails. Pediatr Ann 1993;22:253-259
33. Pariser DM: Topical steroids: A guide for use in the elderly patient. Geriatrics 1991;46:51-63
34. Reynolds RD, Boiko S, Lucky AW: Exacerbation of tinea corporis during treatment with 1% clotrimazole/0.05% betamethasone dipropionate (Lotrisone). Am J Dis Child 1991;145:1224-1225
35. Barkey WF: Striae and persistent tinea corporis related to prolonged use of betamethasone dipropionate 0.05% cream/ clotrimazole 1% cream (Lotrisone cream). J Am Acad Dermatol 1987;117:518-519
36. Borelli D, Jacobs PH, Nall L: Tinea versicolor: Epidemiologic, clinical, and therapeutic aspects. J Am Acad Dermatol 1991;25:300-305
37. Rigopoulos D, Katsambas A, Antoniou C, et al: Facial seborrheic dermatitis treated with fluconazole 2% shampoo, Int J Dermatol 1994;33:136-137
38. McGrath J, Murphy GM: The control of seborrheic dermatitis and dandruff by antipityrosporal drugs. Drugs 1991;41:178-184
39. Carr MM, Pryce DM, Ive FA: Treatment of seborrhoeic dermatitis with ketoconazole: I. Response of seborrhoeic dermatitis of the scalp to topical ketoconazole. Br J Dermatol 1987;116:213-216
40. Green CA, Farr PM, Shuster S: Treatment of seborrhoeic dermatitis with ketoconazole: II. Response of seborrhoeic dermatitis of the face, scalp and trunk to topical ketoconazole. Br J Dermatol 1987:116:217-221
41. Janniger CK: Childhood warts. Cutis 1992:50:15-16
42. Beutner KR: Cutaneous viral infections. Pediatr Ann 1993;22: 247-252
43. Highet AS: Molluscum contagiosum. Arch Dis Child 1992;67: 1248-1249
44. Straus SE: Overview: The biology of varicella-zoster virus infection. Ann Neurol 1994;35:S4-S8 (suppl)
45. Rockley PF, Tyring SK: Pathophysiology and clinical manifestations of Varicella zoster virus infections, Int J Dermatol 1994;33:227-232
46. Feldman S: Varicella-zoster virus pneumonitis. Chest 1994;106: 22S-27S
47. Mamdani FS: Pharmacologic management of herpes zoster and postherpetic neuralgia. Can Fam Physician 1994;40:321-332
48. Marsh RJ, Cooper M: Ophthalmic herpes zoster. Eye 1993;7: 350-370
49. Gilden DH: Herpes zoster with postherpetic neuralgia - persisting pain and frustration. N Engl J Med 1994;330:932-934
50. Wood MJ, Johnson RW, McKendrick MW, et al: A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med 1994;330:896-900
51. Whitley RJ, Gnann JW, Hinthorn D, et al: Disseminated herpes zoster in the immunocompromised host: a comparative trial of acyclovir and vidarabine. J Infect Dis 1992;165:450-455
52. Wagstaff AJ, Faulds D, Goa KL: Aciclovir: A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1994;47:153-205
53. Spangler JG, Kirk JK, Knudson MP: Uses and safety of acyclovir in pregnancy. J Fam Pract 1994;38:186-191
54. Gallant JE, Moore RD, Chaisson RE: Prophylaxis for opportunistic infections in patients with HIV infection. Ann Intern Med 1994;120:932-944
55. Enders G, Miller E, Cradock-Wilson J, et al: Consequences of varicella and herpes zoster in pregnancy: Prospective study of 1739 cases. Lancet 1994;343:1548-1551
56. Chapman S, Duff P: Varicella in pregnancy. Semin Perinatol 1993;17:403-409
57. Asano Y, Suga S, Yoshikawa T, et al: Experience and reason: Twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine. Pediatrics 1994;94:524-526
58. Levin MJ, Murray M, Zerbe GO, et al: Immune responses of elderly persons 4 years after receiving a live attenuated varicella vaccine. J Infect Dis 1994;170:522-526
59. Hardy I, Gershon AA, Steinberg SP, et al: The incidence of zoster after immunization with live attenuated varicella vaccine: a study in children with leukemia. N Engl J Med 1991;325:1545-1550
60. Nader S, Bergen R, Sharp M, et al: Age-related differences in cell-mediated immunity to varicella-zoster virus among children and adults immunized with live attenuated varicella vaccine. J Infect Dis 1995;171:13-17
61. Dagan R: Impetigo in childhood: Changing epidemiology and new treatments. Pediatr Ann 1993;22:235-240
62. Demidovich CW, Wittler RR, Ruff ME, et al: Impetigo: Current etiology and comparison of penicillin, erythromycin, and cephalexin therapies. Am J Dis Child 1990;144:1313-1315
63. Goldfarb J, Crenshaw D, O'Horo J, et al: Randomized clinical trial of topical mupirocin versus oral erythromycin for impetigo. Antimicrob Agents Chemother 1988;32:1780-1783
64. Britton JW, Fajardo JE, Krafte-Jacobs B: Comparison of mupirocin and erythromycin in the treatment of impetigo. J Pediatr 1990;117:827-829
65. Jones J: Investigation upon the nature, causes, and treatment of hospital gangrene as it prevailed in the Confederate armies 1861-1865. New York: U.S. Sanitary Commission, Surgical Memoirs of the War of Rebellion, 1871
66. Janevicius RV, Hann SE, Batt MD: Necrotizing fasciitis. Surg Gynecol Obstet 1982;154:97-102
67. Gannon T: Dermatologic emergencies. Postgrad Med 1994;96: 67-82
68. Umbert IJ, Winkelmann RK, Oliver GF, et al: Necrotizing fasciitis: A clinical, microbiologic, and histopathologic study of 14 patients. J Am Acad Dermatol 1989;20:774-781
69. Chelsom J, Halstensen A, Haga T, et al: Necrotising fasciitis due to group A streptococci in western Norway: Incidence and clinical features. Lancet 1994;344:1111-1115
70. Stevens DL, Tanner MH, Winship J, et al: Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989;321:1-7
71. Atiyeh BC, Zaatari AM: Necrotizing fasciitis of the upper extremity. J Emerg Med 1994;12:611-613
72. Sterling GB, Janniger CK, Kihiczak G, et al: Scabies. Am Fam Physician 1992;46:1237-1241
73. Pruksachatkunakorn C, Duarte AM, Schachner L: Scabies: How to find and stop the itch. Postgrad Med 1992;91:263-269
74. Haag ML, Brozena SJ, Fenske NA: Attack of the scabies: What to do when an outbreak occurs. Geriatrics 1993;48:45-53
75. Huff JC, Weston WL, Tonnesen MG: Erythema multiforme: A critical review of characteristics, diagnostic criteria, and causes. J Am Acad Dermatol 1983;8:763-775
76. Bastuji-Garin S, Rzany B, Stern RS, et al: Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993;129:92-96
77. Stampien TM, Schwartz RA: Erythema multiforme. Am Fam Physician 1992;46:1171-1176
78. Patterson R, Dykewicz MS, Gonzalzles A, et al: Erythema multiforme and Stevens-Johnson syndrome: descriptive and therapeutic controversy. Chest 1990;98:331-336
79. Pariser DM, Phillips PK: Basal cell carcinoma: When to treat it yourself, and when to refer. Geriatrics 1994;49:39-44
80. Ko CB, Walton S, Keczkes K, et al: The emerging epidemic of skin cancer. Br J Dermatol 1994;130:269-272
81. Miller DL, Weinstock MA: Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994;30:774-778
82. Snow SN, Sahl W, Lo JS, et al: Metastatic basal cell carcinoma. Cancer 1994;73:328-335
83. Davids JR, Kolman BH, Billman GF, et al: Subcutaneous granuloma annulare: Recognition and treatment. J Pediatr Orthop 1993;13:582-586
84. Blume-Peytavi U, Zouboulis CC, Jacoby H, et al: Successful outcome of cryosurgery in patients with granuloma annulare. Br J Dermatol 1994;130:494-497
85. Muhlbauer JE: Granuloma annulare. J Am Acad Dermatol 1980;3:217-230
86. Samlaska CP, Sandberg GD, Maggio KL, et al: Generalized perforating granuloma annulare. J Am Acad Dermatol 1992;27:319-322
87. Dabski K, Winkelmann RK: Generalized granuloma annulare: Clinical and laboratory findings in 100 patients. J Am Acad Dermatol 1989;20:39-47
88. Smith JB, Hansen CD, Zone JJ: Potassium iodide in the treatment of disseminated granuloma annulare. J Am Acad Dermatol 1994;30:791-792
89. Caserio RJ, Eaglstein WH, Allen CM: Treatment of granuloma annulare with potassium iodide. J Am Acad Dermatol 1984;10:294 (letter)
90. Schleicher SM, Milstein HJ, Lim SJM, et al: Resolution of disseminated granuloma annulare with isotretinoin. Int J Dermatol 1992;31:371-372
91. Botella-Estrada R, Guillen C, Sanmartin O, et al: Disseminated granuloma annulare: Resolution with etretinate therapy. J Am Acad Dermatol 1992;26:777-778
92. Radcliffe KW: Hidradenitis suppurativa. Genitourin Med 1991; 67:58
93. Carmen C, Yu W, Cook MG: Hidradenitis suppurativa: A disease of follicular epithelium, rather than apocrine glands. Br J Dermatol 1990;122:763-769
94. Edlich RF, Silloway KA, Rodeheaver GT, et al: Epidemiology, pathology, and treatment of axillary hidradenitis suppurativa. J Emerg Med 1986;4:369-378
95. Falanga V: Venous ulceration. J Dermatol Surg Oncol 1993;19: 764-771
96. Angel MF, Ramasastry SS, Swartz WM, et al: The causes of skin ulcerations associated with venous insufficiency: A unifying hypothesis. Plast Reconstr Surg 1987;79:289-297
97. Jamieson WG, DeRose G, Harris KA: Management of venous stasis ulcer: Long-term follow-up. Canad J Surg 1990;33:222-223